Vishwas Setia
Patrimonio netto: 13 M $ in data 30/06/2026
Patrimonio netto: 13 M $ in data 30/06/2026
Vishwas Setia worked as an Investment Banking Summer Associate at Merrill Lynch & Co., Inc. in 2013.
Mr. Setia also worked as Chief Financial Officer at MapLight Therapeutics, Inc. from 2024 to 2026.
Mr. Setia completed an MBA degree at Kellogg School of Management in 2014 and holds an undergraduate degree from Delhi College of Engineering.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/05/2026 | 356.256 ( 0,84% ) | 13 M $ | 30/06/2026 |
| Società | Posizione | Fine |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Direttore Finanziario/CFO | 18/06/2026 |
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01/08/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Delhi College of Engineering
Delhi College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale